AIHealthTech.io — Intelligence Library
In-depth analysis on AI, diagnostics, genomics, drug discovery, and the future of medicine.
Joint Commission AI certification assesses hospital governance, safeguards, monitoring, and training. It does not certify individual AI tools or accuracy.
How an FDA PCCP lets an AI medical device update without a new 510(k) or PMA supplement, with planned changes, validation, and…
TEFCA QHIN interoperability in 2026: review 11 designated networks, confirmed exchange volume, and questions hospitals should weigh before connecting.
DEA telemedicine controlled substance prescribing in 2026: what expires December 31, how Medicare dates differ, and what the rulemaking forecast means.
How MDR and AI Act rules make medical device AI high-risk: the two-condition test, Rule 11, notified-body review and what application dates…
FDA generative AI medical device regulation is open for discussion. Learn the risk framework and how to comment by October 19, 2026,…
Pseudonymized vs. anonymized health data under GDPR: what the IQVIA fine, Recital 26 and the CJEU ruling mean for assessing re-identification risk.
The EU AI Act medical device deadline moves to 2 August 2028 for Annex I high-risk AI. See the revised timeline and…
Deploying one AI model across a health system forces revalidation at every hospital, and the operational cost is real. Here is how…
Healthcare professionals face a growing challenge: an overwhelming volume of scattered patient data leading to cognitive overload and information fragmentation. This article…